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Potentially preventable maternal infections are increas-
ingly recognized as being a cause of fetal death or still-
birth. McClure and Goldenberg maintain that infection
causes 20% to 40% of fetal deaths in developed and
developing countries respectively [1]. Infection causes
embryonic, fetal, and perinatal death by multiple
mechanisms including:
1) direct, blood borne placental infection (via maternal
blood stream),
2) ascending vaginal infection through the cervix,
3) iatrogenic infection (such as amniocentesis and
“membrane stripping”), and
4) persistent uterine infection already present during
implantation [2].
More recently recognized mechanisms include:
1) combined viral and microbial infections, in which
placental viral infection sensitizes to the effects of bac-
terial lipopolysaccharide [3],
2) “graft vs. host” immunologic phenomena in which
ongoing or preceding infections may potentiate maternal
and/or fetal inflammatory rejection mechanisms, and
3) “sterile inflammation” considered to be due to
innate immune or “autophagic” mechanisms which are
required to remove dead cells caused by “senescence” or
apoptosis [4].
The types of microbes causing stillbirth vary by loca-
tion, population, and occupational factors. These include
all taxa of microbes: bacteria, mycoplasmas, viruses
(entero and herpes viruses), fungi (yeasts), rickettsia
(Q-fever and Rocky Mountain spotted fever), parasites
(toxoplasmosis), and possibly nematodes and transpo-
sons or prions.
Infection-caused stillbirth or septic miscarriage occurs
when invasive microorganisms either overwhelm
embryonic or fetal innate and adaptive immune host
defense mechanisms or cause sufficient cell and tissue
death to result in the death of the entire placenta and
embryo or fetus. Less extensive intrauterine infections or
inflammation can also damage the developing embryo or
fetus causing lifetime disability. We now understand that
host immune cells and tissue pathophysiologic “death
mechanisms” can stimulate necrosis (death of internal
cell organelles) or apoptosis (due to “death program-
ming”) cell signalling [5]. Both processes may cause con-
siderable organ damage in vulnerable organs, especially
the central nervous system and special sense organs
(retina, hearing organs) without causing “cardiac death”
clinically recognizable by loss of heartbeat. As an exam-
ple, Group B streptococcus (GBS) is widely recognized to
cause lifelong brain injury from meningoencephalitis or
systemic “FIRS” (fetal inflammatory reaction syndrome.)
Infection-caused stillbirth may occur as isolated cases
(syphilis) or in epidemics (Q-fever or foodborne Listeria
infection.)
Successful programs prevent prevalent causes of infec-
tion-caused stillbirth depend upon:
1) recognition of the problem,
2) means to identify the agent, and
3) effective means to treat intrauterine infections.
Prevention of GBS infection is an example of pro-
grammatic primary prevention of septic stillbirth
through identification and treatment of GBS urinary
tract infection or asymptomatic bacteriuria with penicil-
lin followed by test of cure (TOC) [6].
Other successful examples of secondary prevention are
anti-syphilis and anti-HIV programs which unite maternal
screening and indicated treatments. Primary prevention
(before maternal infection) of infection-causing reproduc-
tive loss depends on the knowledge of the epidemiology
and pathophysiology of the particular infectious agents.
Examples include preventing rubella and varicella by
vaccinations, listeriosis via milk pasteurization, and malaria
by using mosquito netting. Prevention of more recently
understood causes, such as ascending in utero infection
due to GBS, BV, or associated vaginal microflora, will
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require new care practice strategies including expanded
screening and maternal vaccination. Such prenatal pro-
grammatic change will require a concerted and organized
effort.
In Germany, weekly vaginal pH screening using a
sensitive indicator (increased vaginal pH over 4.7) has
been used to indicate the need for specific microbial
testing and treatment. Other approaches to preventing
ascending vaginal infection include specific screening
for prevalent abnormal microflora (vaginitis, GBS, or
sexually transmitted infections) in populations at risk.
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